Scott Kapnick serves as Executive at AILERON THERAPEUTICS INC, where they oversee executive responsibilities. Since joining the company, Scott Kapnick has executed 4 insider transactions totaling $4.4M, demonstrating a bullish approach to their equity position. Their most recent transaction on Jul 5, 2017 involved purchasing 66,666 shares valued at $1000.0K.
Scott Kapnick currently holds 66,666 shares of AILERON THERAPEUTICS INC (ALRN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Scott Kapnick has been a net buyer of ALRN stock. They have purchased $4.4M and sold $0 worth of shares.
Scott Kapnick's most recent insider trade was on Jul 5, 2017, when they purchased 66,666 shares at $15.00 per share.
Get notified when new Form 4 filings are submitted
| $15.00 |
| Discretionary |
| Jul 5, 2017 | ALRN | $0 | Conversion | 285,438 | $N/A | Discretionary |
| Jul 5, 2017 | ALRN | $2.4M | Purchase | 159,307 | $15.00 | Discretionary |